FDCDDQ
CLSD

Federation des caisses Desjardins du Quebec’s Clearside Biomedical CLSD Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10
Closed -$1.19K – 2170
2017
Q1 		$1.19K Buy
+10
New +$1.18K ﹤0.01% 1686

Other funds holding CLSD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's CLSD Position: Q2 2017 in Review

Federation des caisses Desjardins du Quebec sold out of Clearside Biomedical (CLSD) in Q2 2017, closing a stake of 10 shares — an estimated $1.19K sold.

Federation des caisses Desjardins du Quebec first reported a position in CLSD in Q1 2017 and held it in 1 quarter. The position peaked at $1.19K in Q1 2017. 53 funds tracked by Wall St. Rank hold CLSD as of Q2 2017.

  • Federation des caisses Desjardins du Quebec reported no remaining Clearside Biomedical position as of Q2 2017 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 10 Clearside Biomedical shares in Q2 2017, an estimated $1.19K.
  • Federation des caisses Desjardins du Quebec first reported a position in Clearside Biomedical in Q1 2017 and held it in 1 quarter.
  • Federation des caisses Desjardins du Quebec's Clearside Biomedical position peaked at $1.19K in Q1 2017.
  • 53 funds tracked by Wall St. Rank held Clearside Biomedical as of Q2 2017.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2017, filed 30 Aug 2024.